CD36 as a biomarker of atherosclerosis

Burak Yazgan1, Seyfettin Ustunsoy1, Betul Karademir1

  • 1Department of Biochemistry, Faculty of Medicine, Genetic and Metabolic Diseases Research Center, Marmara University, Istanbul, Turkey.

Insights

CD36 mRNA levels in peripheral blood mononuclear cells can indicate atherosclerosis progression. This finding suggests a potential non-invasive diagnostic marker for the chronic inflammatory arterial disease.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Medicine

Background:

  • Atherosclerosis is a chronic inflammatory disease characterized by arterial wall damage, smooth muscle cell proliferation, and plaque formation.
  • Oxidized low-density lipoproteins (oxLDL) are key drivers, activating cellular responses and contributing to atherosclerotic plaque development.
  • Scavenger receptors, particularly CD36, play a critical role by binding oxLDL and mediating lipid transport in macrophages and foam cells within lesions.

Purpose of the Study:

  • To investigate the correlation between CD36 mRNA expression in aortic tissue and peripheral blood mononuclear cells (PBMCs) in a cholesterol-induced atherosclerosis model.
  • To determine if CD36 mRNA levels in PBMCs can serve as a surrogate marker for atherosclerosis in aortic tissue.

Main Methods:

  • Cholesterol-induced atherosclerosis was established in rabbits.
  • CD36 mRNA expression was quantified in both aortic tissue and PBMCs.
  • Macroscopic and microscopic examinations were used to assess atherosclerotic lesions.

Main Results:

  • Cholesterol-fed rabbits developed typical atherosclerotic lesions in their aortas.
  • CD36 mRNA expression was significantly increased in the aortas of these rabbits.
  • Importantly, CD36 mRNA levels in PBMCs were found to correlate with those in the aortic tissue.

Conclusions:

  • CD36 mRNA expression in PBMCs serves as a reliable indicator of CD36 mRNA levels in the aorta during cholesterol-induced atherosclerosis.
  • PBMC CD36 mRNA levels may represent a valuable, non-invasive biomarker for diagnosing and monitoring atherosclerosis.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
754
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
750
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
822